These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 9829487

  • 1. The compositional abnormalities of lipoproteins in diabetic renal failure.
    Attman PO, Knight-Gibson C, Tavella M, Samuelsson O, Alaupovic P.
    Nephrol Dial Transplant; 1998 Nov; 13(11):2833-41. PubMed ID: 9829487
    [Abstract] [Full Text] [Related]

  • 2. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO, Alaupovic P, Tavella M, Knight-Gibson C.
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [Abstract] [Full Text] [Related]

  • 3. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
    Hughes TA, Gaber AO, Amiri HS, Wang X, Elmer DS, Winsett RP, Hathaway DK, Hughes SM, Ghawji M.
    Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM, Knight-Gibson C, Samuelsson O, Attman PO, Wang CS, Alaupovic P.
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [Abstract] [Full Text] [Related]

  • 5. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O, Attman PO, Knight-Gibson C, Kron B, Larsson R, Mulec H, Weiss L, Alaupovic P.
    Nephron; 1997 Jan; 75(3):286-94. PubMed ID: 9069450
    [Abstract] [Full Text] [Related]

  • 6. Dyslipoproteinemia in diabetic renal failure.
    Attman PO, Nyberg G, William-Olsson T, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1992 Dec; 42(6):1381-9. PubMed ID: 1474769
    [Abstract] [Full Text] [Related]

  • 7. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO, Samuelsson O, Alaupovic P.
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [Abstract] [Full Text] [Related]

  • 8. Alterations in lipoprotein composition in peritoneal dialysis patients.
    Moberly JB, Attman PO, Samuelsson O, Johansson AC, Knight-Gibson C, Alaupovic P.
    Perit Dial Int; 2002 Dec; 22(2):220-8. PubMed ID: 11990407
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.
    Sehayek E, Eisenberg S.
    J Biol Chem; 1991 Sep 25; 266(27):18259-67. PubMed ID: 1917954
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
    Hughes TA, Stentz F, Gettys T, Smith SR.
    Metabolism; 2006 Jan 25; 55(1):26-34. PubMed ID: 16324916
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
    Attman PO, Alaupovic P.
    Nephron; 1991 Jan 25; 57(4):401-10. PubMed ID: 2046821
    [Abstract] [Full Text] [Related]

  • 15. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
    Ryomoto KI, Suzuki M, Kanazawa A, Hasegawa M, Kimura Y, Yamamura T, Harano Y.
    Am J Hypertens; 2000 Jun 25; 13(6 Pt 1):617-24. PubMed ID: 10912744
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
    Zhang X, Nie Y, Gong Z, Zhu M, Qiu B, Wang Q.
    Front Endocrinol (Lausanne); 2022 Jun 25; 13():915575. PubMed ID: 35937834
    [Abstract] [Full Text] [Related]

  • 18. Serum lipid metabolism abnormalities and change in lipoprotein contents in patients with advanced-stage renal disease.
    Tsumura M, Kinouchi T, Ono S, Nakajima T, Komoda T.
    Clin Chim Acta; 2001 Dec 25; 314(1-2):27-37. PubMed ID: 11718676
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.